A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

NCT06647745 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Hypertension

Interventions

DRUG: THP-00101
DRUG: THP-00102
DRUG: THP-00103
DRUG: THP-00104
DRUG: THP-00105
DRUG: THP-00106

Sponsor

THPharm Corp.